NYSE:EHC - New York Stock Exchange, Inc. - US29261A1007 - Common Stock - Currency: USD
97.53
-2.36 (-2.36%)
The current stock price of EHC is 97.53 USD. In the past month the price increased by 5.69%. In the past year, price increased by 32.74%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 14.3 | 80.15B | ||
BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 14.59B | ||
THC | TENET HEALTHCARE CORP | 10.89 | 12.32B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 12.12 | 11.88B | ||
ENSG | ENSIGN GROUP INC/THE | 22.97 | 7.26B | ||
ACHC | ACADIA HEALTHCARE CO INC | 11.29 | 3.68B | ||
SGRY | SURGERY PARTNERS INC | 26.95 | 3.22B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 8.6 | 2.92B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 9.02 | 2.28B | ||
PACS | PACS GROUP INC | 16.83 | 1.98B | ||
ARDT | ARDENT HEALTH PARTNERS INC | 36.58 | 1.98B | ||
NHC | NATIONAL HEALTHCARE CORP | 11.74 | 1.45B |
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama and currently employs 22,356 full-time employees. The firm provides specialized rehabilitative treatment on an inpatient basis. The company operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. The company operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The firm provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
ENCOMPASS HEALTH CORP
9001 Liberty Pkwy
Birmingham ALABAMA 35242 US
CEO: Mark J. Tarr
Employees: 27253
Company Website: https://www.encompasshealth.com/
Investor Relations: https://investor.encompasshealth.com
Phone: 12059677116
The current stock price of EHC is 97.53 USD. The price decreased by -2.36% in the last trading session.
The exchange symbol of ENCOMPASS HEALTH CORP is EHC and it is listed on the New York Stock Exchange, Inc. exchange.
EHC stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed EHC and the average price target is 119.09 USD. This implies a price increase of 22.1% is expected in the next year compared to the current price of 97.53. Check the ENCOMPASS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENCOMPASS HEALTH CORP (EHC) has a market capitalization of 9.83B USD. This makes EHC a Mid Cap stock.
ENCOMPASS HEALTH CORP (EHC) currently has 27253 employees.
ENCOMPASS HEALTH CORP (EHC) has a support level at 99.62 and a resistance level at 103.2. Check the full technical report for a detailed analysis of EHC support and resistance levels.
The Revenue of ENCOMPASS HEALTH CORP (EHC) is expected to grow by 9.12% in the next year. Check the estimates tab for more information on the EHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ENCOMPASS HEALTH CORP (EHC) has a dividend yield of 0.68%. The yearly dividend amount is currently 0.6. Check the full fundamental report for a detailed analysis of EHC dividend history, reliability and sustainability.
ENCOMPASS HEALTH CORP (EHC) will report earnings on 2025-04-22, after the market close.
The PE ratio for ENCOMPASS HEALTH CORP (EHC) is 22.02. This is based on the reported non-GAAP earnings per share of 4.43 and the current share price of 97.53 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHC.
The outstanding short interest for ENCOMPASS HEALTH CORP (EHC) is 1.5% of its float. Check the ownership tab for more information on the EHC short interest.
ChartMill assigns a technical rating of 9 / 10 to EHC. When comparing the yearly performance of all stocks, EHC is one of the better performing stocks in the market, outperforming 81.03% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to EHC. While EHC has a great profitability rating, there are quite some concerns on its financial health.
Over the last trailing twelve months EHC reported a non-GAAP Earnings per Share(EPS) of 4.43. The EPS increased by 21.7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.04% | ||
ROA | 6.5% | ||
ROE | 21.41% | ||
Debt/Equity | 1.2 |
ChartMill assigns a Buy % Consensus number of 87% to EHC. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of 8.86% and a revenue growth 9.12% for EHC